Editor's Note The Joint Commission, on August 2, announced that it had updated its Health Care Equity (HCE) Accreditation Standards & Resource Center and its HCE Certification Resource Center. A new resource available in the HCE Accreditation Standards & Resource Center is an On Demand Accelerate PI Webinar that provides…
Editor's Note The US News & World Report, on August 1, released its 2023-2024 Best Hospitals Honor Roll. Just 22 hospitals out of nearly 5,000 evaluated for the Best Hospitals rankings and ratings made the Honor Roll, which examines hospitals in more than 30 medical and surgical services. In alphabetical…
Editor's Note The Food and Drug Administration (FDA), on August 1, identified the recall by Baxter Healthcare Corporation of its SIGMA Spectrum Infusion Pump with Master Drug Library (Version 8) and Spectrum IQ Infusion System with Dose IQ Safety Software (Version 9) as Class I, the most serious. The recall…
Editor's Note The Food and Drug Administration (FDA), on July 28, identified the recall by GE HealthCare of its TruSignal SpO2 [arterial oxygen saturation] sensors as Class I, the most serious. The recall was initiated because of issues that may reduce the amount of energy sent to the heart during…
Editor's Note This French study examines the rate of medical confidentiality breaches in tweets by anesthesiology and intensive care healthcare workers (HCWs). Data from 431 tweets with photographs and 9,000 text-only tweets from 1,831 accounts were included in the analysis. Among the findings: There were 44 (10.2%) breaches of medical…
Editor's Note This prospective multi-institutional, multi-country study led by researchers from the University of Sydney, Australia, finds that as few as 4 to 5 minutes of vigorous intermittent physical activity (VILPA) daily is associated with a substantially lower cancer risk. VILPA refers to brief and sporadic (eg, up to 1…
Editor's Note The Food and Drug Administration (FDA), on July 27, identified the recall by Abiomed of all Impella Left Sided Blood Pumps as Class I, the most serious. Abiomed is recalling the pumps because the instructions for use do not adequately address precautions to take when treating transcatheter aortic…
Editor's Note The Food and Drug Administration (FDA), on July 26, identified the recall by Abbott of its Amplatzer Steerable Delivery Sheath as Class I, the most serious. Abbott is recalling the sheath because of an increased risk for air emboli being introduced into patients who have cardiac catheterization procedures…
Editor's Note The Joint Commission, on July 19, announced that it and the National Quality Forum (NQF) are accepting applications for the 2023 John M. Eisenberg Patient Safety and Quality Awards through August 7. The awards, which recognize major achievements by individuals and organizations in their use of innovative approaches…
Editor's Note The Joint Commission, on July 19, announced that it has revised its Medication Compounding (MC) chapter for home care organizations and the Medication Compounding Certification (MDC) program, which is available to accredited hospitals, critical access hospitals, and home care pharmacy organizations. Among the revisions: Revising the requirements to…